Search
Search results
15 results found
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030
Parsons, H A, T Blewett, X Chu, S Sridhar, K Santos, K Xiong, V G Abramson, et al. 2023. “Circulating Tumor DNA Association With Residual Cancer Burden After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer in TBCRC 030”. Ann Oncol 34 (10): 899-906.
FDX1 regulates cellular protein lipoylation through direct binding to LIAS
Dreishpoon, Margaret B., Nolan R. Bick, Boryana Petrova, Douglas M. Warui, Alison Cameron, Squire J. Booker, Naama Kanarek, Todd R. Golub, and Peter Tsvetkov. 2023. “FDX1 Regulates Cellular Protein Lipoylation through Direct Binding to LIAS”. BioRxiv.
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma
Hofman, Damon A., Jorge Ruiz-Orera, Ian Yannuzzi, Rakesh Murugesan, Adam Brown, Karl R. Clauser, Alexandra L. Condurat, et al. 2023. “Translation of Non-Canonical Open Reading Frames As a Cancer Cell Survival Mechanism in Childhood Medulloblastoma”. BioRxiv.
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Baumgartner, Christina K., Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, Keith M. Hamel, Kira E. Olander, Thomas G. R. Davis, Kathleen A. McGuire, et al. 2023. “The PTPN2/PTPN1 Inhibitor ABBV-CLS-484 Unleashes Potent Anti-Tumour Immunity”. Nature 622 (7984): 850-62.